Skip to content

Author

Halil Şenol

We have 5 of 50 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Thiophen-2-ylsulfonyl indole-3-carbaldehyde thiosemicarbazones as selective prostate cancer agents: biological profiling and molecular targeting studies

A series of thiophen-2-ylsulfonyl indole-3-carbaldehyde thiosemicarbazone derivatives 5a–5t was synthesized and evaluated for anticancer activity using biological and computational methods. The cytotoxic activity of these compounds was tested on A549, LNCaP, and HUVEC cell lines utilizing the MTT assay, with sorafenib...

Kazma Batool, Hande İpek İnce, A. Şenol et al. · 0 citations
Oct 2026

N-(3-Trifluoromethylphenyl)sulfonyl-indole-3-carbaldehyde thiosemicarbazones induce apoptosis and modulate p53-associated signaling in prostate cancer: integrated experimental and computational studies.

Prostate cancer continues to be an important therapeutic challenge that demands the development of new apoptosis-inducing agents. In the present study, a series of N-(3-trifluoromethylphenyl)sulfonyl-indole-3-carbaldehyde thiosemicarbazone derivatives (5a-s) was synthesized and evaluated for their biological activity a...

Khadija-tul Kubra, Özden Özgün Acar, Ayşe Merve Şenol et al. · 0 citations
Aug 2026

Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer.

The present study identifies compounds 2 and 3 as promising lead candidate that combines potent and selective antiproliferative activity, strong tubulin polymerization inhibition, and favorable binding characteristics compared with paclitaxel.

F. S. Tokalı, Şeyma Ateşoğlu, Pelin Tokalı et al. · 1 citation
Aug 2026

Synthesis, Computational Chemical Study, Molecular Docking, Dynamics Simulations, and Anti-Diabetic Potential of the Perfluorophenyl Acetamide Derivative

Results indicate this acetamide behaves as a competitive inverse agonist of 5-HT1B subtype receptor and the pharmacophore model of PFPA for interaction with 5-HT1BR was proposed.

Ulviyya Askerova, Gulnara Akverdieva, S. Demukhamedova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.